← Eichor
Study identifier: NCT06449664 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Training for Men Undergoing Androgen Deprivation Therapy.

Condition: Prostate Cancer  ·  Sponsor: The Swedish School of Sport and Health Sciences

PhaseNA
Planned participants60
Who can joinMale, 50 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate the effects of a newly developed training concept on men with prostate cancer undergoing androgen deprivation therapy (ADT). The main questions it aims to answer are: * How feasible and safe is the new training concept? * How efficient is the training concept to counteract side effects caused by ADT? Researchers will compare the new training concept with usual care to evaluate how efficient the training concept is to counteract the ADT-related side effects. Participants in the intervention group will perform the new training concept twice weekly for 12 weeks. Participants in the control group will only receive usual care. All participants will visit the laboratory at baseline and after 6 and 12 weeks to measure the primary and secondary outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Niklas Psilander, PhD  ·  +46 8 120 538 23  ·  niklas.psilander@gih.se

Always discuss trial participation with your own doctor first.

Locations (1)

Swedish School of Sport and Health SciencesStockholm, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06449664